Stocks-GILD-Gilead Sciences Inc

GILD Gilead Sciences Inc

77.72 0 (0%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: Gilead Sciences Inc's revenues decreased by 0.09% and amounted to 27.28B. Net income decreased by 26.37% to 4.57B. Net assets increased by 0.69% to 21.21B and EPS decreased from 4.93 to 3.64.
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
Net Profit Margin
Operating Margin
Return On Investment